معرفی
Henrik Zetterberg is a Professor in Neurochemistry at the University of Gothenburg, specializing in neurodegenerative diseases such as Alzheimer's and Parkinson's. He focuses on developing biomarkers for early disease detection, including a groundbreaking blood test for Alzheimer's that measures tau protein variants. His research emphasizes the importance of identifying preclinical changes long before symptom onset to enable timely intervention.
- Affiliations: University of Gothenburg, Department of Neurochemistry
- Education: Medical training with specialization in neurology and neurochemistry
Key research interests include biochemical markers in spinal fluid and blood, neurofilament proteins as indicators of nerve damage, and the role of vascular risk factors in neurodegeneration. Zetterberg pioneered the use of neurofilament light chain (NfL) as a universal biomarker for nervous system injury across diseases like multiple sclerosis and spinal muscular atrophy.
His work bridges clinical practice and drug development, with breakthroughs such as stabilizing mRNA therapies for spinal muscular atrophy, demonstrated through reduced neurofilament levels. Future challenges involve advancing treatments for neurodegenerative diseases and refining diagnostic tools for widespread clinical use.
Awards: Wallenberg Academy Fellow
Grants & Collaborations: Multiple grants supporting biomarker research, collaborations on mRNA therapies, and clinical trials for diagnostic tools.
Labs/Teams: Leads neurochemistry research teams at the University of Gothenburg, collaborating with global institutions on biomarker development and neurodegenerative disease studies.
